Financial Information | Regeneron Pharmaceuticals Inc.

Filing date	Form	Description	View
May 05, 2004	4	Statement of changes in beneficial ownership of securities	View HTML 0001254560-04-000004.pdf 0001254560-04-000004.xls
May 05, 2004	4	Statement of changes in beneficial ownership of securities	View HTML 0001254560-04-000005.pdf 0001254560-04-000005.xls
May 05, 2004	SC 13G/A	An amendment to the SC 13G filing	View HTML 0001193125-04-079147.pdf 0001193125-04-079147.xls
Apr 29, 2004	424B3	Form of prospectus reflecting facts events constituting substantive change from last form	View HTML 0000950123-04-005343.pdf 0000950123-04-005343.xls
Apr 28, 2004	8-K	Report of unscheduled material events or corporate event	View HTML 0000950123-04-005322.pdf 0000950123-04-005322.xls
Apr 27, 2004	8-K	Report of unscheduled material events or corporate event	View HTML 0000950123-04-005202.pdf 0000950123-04-005202.xls
Apr 23, 2004	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-04-000027.pdf 0001237899-04-000027.xls
Apr 23, 2004	424B3	Form of prospectus reflecting facts events constituting substantive change from last form	View HTML 0000950123-04-005015.pdf 0000950123-04-005015.xls
Apr 23, 2004	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	View HTML 0001206774-04-000384.pdf 0001206774-04-000384.xls
Apr 16, 2004	4/A	Amendment to a previously filed 4	View HTML 0001237899-04-000025.pdf 0001237899-04-000025.xls

Data provided by Kaleidoscope.

Investors & Media